Last updated: 2026-10-20 07:36:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
ClearPoint Neuro, Inc. (CLPT) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $9,17, with a market capitalization of $276,67M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $8,27 to $28,10. This page covers its latest market performance, valuation, price trends and company information.
$276,67M | |
$9,11 | |
$31,29 | |
$2,86 | |
$9,07 | |
411,84K | |
665,54K | |
-- | |
$28,10 | |
$8,27 | |
-- | |
-- |
ClearPoint Neuro, Inc. (CLPT) last closed at $9,07 as of 2026-10-19 23:31:00, unchanged from the previous close of $9,07.
During the latest regular trading session, CLPT traded between $2,86 and $31,29, with a volume of 411,84K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, ClearPoint Neuro, Inc. (CLPT) moved from $10,48 to $9,17, representing a decline of 12,51% ($1,31).
The stock traded between $8,95 and $10,60 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 693,98 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 4,5%
CLPT is currently trading at $9,17, placing it 4,5% of the way from its 52-week low of $8,27 to its 52-week high of $28,10. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
ClearPoint Neuro Inc is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The company's business consists of two integrated components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. The Company operates in one reportable segment.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 172 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of ClearPoint Neuro, Inc. (CLPT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.